Seragon Publishes Data for Longevity Drug SRN-901 Showing Significant Lifespan and Healthspan Extension

Novel combinatorial oral therapy extended median remaining lifespan in adult mice by 33% compared to placebo Treatment resulted in a 70% attenuation of frailty progression and 30.53% reduction in tumor incidence, highlighting significant improvements in physiological resilience...